Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:02 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.90 | 0.83 | 9.05 |
| EPS, GAAP | 0.78 | 0.44 | 0.44 |
| Consensus Estimate | 1.24 | 1.22 | 1.64 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.91 | 3.91 | 1.89 |
| EPS, GAAP | 3.65 | 3.65 | 8.93 |
| Consensus Estimate | 5.22 | 5.54 | -5.75 |
| NVS | Industry Average | |
| P/E (TTM) | 17.60 | NA |
| P/E (Forward) | 13.66 | NA |
| PEG Ratio | 2.59 | 2.20 |
| Price/Sales | 2.98 | 18.91 |
| Beta | 0.28 | 0.70 |
| 11:55 AM | 4/3/2013 | Merck Unit, Sun Pharma File Patent Suit Against Glenmark |
| 11:00 AM | 4/1/2013 | MARKET SNAPSHOT: U.S. Stocks Retreat After Manufacturing Data |
| 4/5/2013 | The Case for Target and a Few Undertakers (Barrons.com) |
| 4/2/2013 | The Multinational's Emerging Market Conundrum (Barrons.com) |
| 3/23/2013 | Healthy Upside for Drug Stocks (Barrons.com) |
| 3/4/2013 | A Generic Rx for Success (Barrons.com) |
| 2/20/2013 | Stocks for a Rich Market (Barrons.com) |
| 2/9/2013 | Off the Critical List and Onto the Buy List (Barrons.com) |
| 1/17/2013 | Jefferies Top Global Pharmaceutical Stock Picks for 2013 (JEF, ABBV, NVS, SNY, PFE) (24/7 Wall St) |
| 1/11/2013 | Best Big Pharma Bets for 2013 (Barrons.com) |
